Within the World of Cancer and Tumors, the 'lingo' being used in everyday communications is forever changing, and is at times, difficult to keep up with. We have gotten used to such terms and acronyms as Xray, MRI, fMRI, CT, PET, Chemo, and so it goes on.
Now, Australian researchers have launched another new tab to describe fluoroethyltyrosine, or FET. Developed in trials by Cooperative Research Centre, Biomedical Imaging Developments, Melbourne, have shown that radio active amino acids are able to double the scans to locate active tumor cells in the brain.
Identifed as FET, fluoroethyltyrosine is injected into a patient prior to scanning the tumor. Used in conjunction with a PET (position emission tomography) scan, it correctly identifies patients needing treatment; FET pinpointing accurately active tumor cells in the brain.
A research spokesman said tumors require large amounts of amino acids to support abnormal growth, FET distinguishing active cancer tumor cells against normal brain tissue. Geoff.
Acknowledement theage.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment